Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/13/1989 | DE3843729A1 Heat-resistant sarcosine oxidase N gene |
07/12/1989 | EP0323900A1 Attenuated viruses |
07/12/1989 | EP0323838A2 Expression vector and method for controllable production of proteins in eukaryotes |
07/12/1989 | EP0323806A1 Novel chimeric antibodies |
07/12/1989 | EP0323805A2 Novel antibodies |
07/12/1989 | EP0323802A2 Monoclonal antibodies against, and cell surface antigen of, lung carcinoma |
07/12/1989 | EP0323782A1 Stabilized protoplasts |
07/12/1989 | EP0323722A1 Compositions and method for recombinant production of crotalidus venom fibrolase |
07/12/1989 | EP0323708A1 Rotavirus reassortant vaccine |
07/12/1989 | EP0323489A1 Preparation of novel protein sweeteners |
07/12/1989 | EP0323480A1 Genetically engineered vaccines for mycobacteria |
07/12/1989 | EP0323473A1 Transformation of an organism using antisense rna or promoter occlusion technique |
07/12/1989 | CN1033838A Ribozymes |
07/11/1989 | US4847201 DNA encoding for CSF-1 and accompanying recombinant systems |
07/11/1989 | US4847165 Ribonucleic acid recovery |
07/11/1989 | US4847080 Genetic engineering |
07/11/1989 | EP0304481A4 Monoclonal antibodies produced against glomerular proteoglycans. |
07/11/1989 | CA1257212A1 Junction-fragment probes and probe clusters |
07/06/1989 | DE3743848A1 Expression of the virally encoded protease P2A of HRV2 |
07/05/1989 | EP0323152A2 Method of synthesizing oligonucleotides |
07/05/1989 | EP0323149A2 Vectors and compounds for expression of zymogen forms of human protein C |
07/05/1989 | EP0323081A2 Method for producing the XbaI restriction endonuclease and methylase |
07/05/1989 | EP0322870A2 Synthetic plasmid, transformant, feline interferon gene and method for producing feline interferon |
07/05/1989 | EP0322712A2 DNA sequences specific for malaria, their expression products and applications thereof |
07/05/1989 | EP0322677A2 Carrier for DNA-hybridization |
07/05/1989 | EP0322533A1 Bordetella pertussis toxin with altered toxicity |
07/05/1989 | EP0322417A1 Empty viral capsid vaccines |
07/05/1989 | CN1033646A Microorganism having low acetate forming capability and process for production of useful substrate using same |
07/05/1989 | CN1033645A Controlling technique of plant virosis and gene engineering |
07/04/1989 | US4845197 Monoclonal antibodies and methods for fungal pathogen detection |
07/04/1989 | US4845076 Antiinflammatory agent |
07/04/1989 | US4845075 Biologically active B-chain homodimers |
07/04/1989 | US4845037 Biosynthesis with micromonospora |
07/04/1989 | US4845031 Recombinant DNA process for producing useful polypeptides |
07/04/1989 | US4845026 Medical diagnosis and monitoring |
07/04/1989 | CA1256825A1 Method and apparatus for sorting particles |
07/04/1989 | CA1256814A1 Method for producing interferons |
07/04/1989 | CA1256795A1 Anti-idiotype antibodies induced by synthetic polypeptides |
06/29/1989 | WO1989005864A1 Transgenic testing systems for mutagens and carcinogens |
06/29/1989 | WO1989005859A1 Agrobacterium mediated transformation of germinating plant seeds |
06/29/1989 | WO1989005858A1 Cucumber mosaic virus coat protein gene |
06/29/1989 | WO1989005857A1 A METHOD OF SIMULTANEOUSLY PRODUCING A LARGE NUMBER OF Leu17-VIP-ANALOGS AND NEW Leu17-VIP-ANALOGS |
06/29/1989 | WO1989005856A1 Vaccines |
06/29/1989 | WO1989005854A1 A novel steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor |
06/29/1989 | WO1989005852A1 Ribozymes |
06/29/1989 | WO1989005824A1 Site-specific homogeneous modification of polypeptides to facilitate covalent linkages to a hydrophilic moiety |
06/29/1989 | WO1989005823A1 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
06/29/1989 | WO1989005816A1 Cellular toxic conjugates |
06/29/1989 | WO1989005658A1 Proteins and process for preparing them, dna sequences, antibodies and their application, poxvirus, transformed or infected cells and pharmaceutical compositions useful for preventing toxoplasmosis |
06/28/1989 | EP0322394A2 Expression of HIV proteins in E. coli and S. cerevisiae |
06/28/1989 | EP0322237A1 Vaccines |
06/28/1989 | EP0322226A2 Site-directed mutagenesis modified glycoprotein hormones and methods of use |
06/28/1989 | EP0322146A2 Antibody and antigen |
06/28/1989 | EP0322115A2 Genetic detoxification of pertussis toxin |
06/28/1989 | EP0322094A1 N-terminal fragments of human serum albumin |
06/28/1989 | EP0322032A2 One-step enzymatic conversion of cephalosporin C and derivatives to 7-aminocephalosporanic acid and derivatives |
06/28/1989 | EP0321973A2 Expression of the virally encoded protease P2A of HRV2 |
06/28/1989 | EP0321940A2 An improved method for the preparation of natural human growth hormone in pure form |
06/28/1989 | EP0321842A1 Soluble recombinant Fc-Epsilon-receptor, the preparation and the use thereof |
06/28/1989 | EP0321749A1 Method for the production of monoclonal antibodies and of cell lines |
06/28/1989 | EP0321606A1 Cellular amphipatic proteins in aggregated forms, and procedure for the production and purification of these proteins |
06/28/1989 | EP0321554A1 Detection of lymphocyte amplification. |
06/28/1989 | EP0321548A1 Novel amphiphilic nucleic acid conjugates |
06/28/1989 | EP0321546A1 Immunoassay for aromatic ring containing compounds |
06/28/1989 | EP0321526A1 Cloning and expression of human tissue factor |
06/28/1989 | EP0150309B1 Hybridoma antibody |
06/27/1989 | US4843155 Guanidinium salt and phenol as solvent |
06/27/1989 | US4843019 Monoclonal antibodies |
06/27/1989 | US4843012 Novel composition for nucleic acid purification |
06/27/1989 | US4843006 Genetic vectors |
06/27/1989 | US4843003 Process for producing shortened target DNA fragments usable in sequencing large DNA segments |
06/27/1989 | US4843002 Apramycin resistance |
06/27/1989 | US4842999 Canine heartworm vaccine and diagnostic test |
06/27/1989 | US4842996 Probes comprising modified adenine groups, their preparation and their uses |
06/22/1989 | DE3742049A1 Preparation and use of vaccines and diagnostic aids for viral diseases and cancers |
06/21/1989 | EP0321362A1 Retinoic acid receptor and derivatives thereof, DNA endocing either substance and use of the proteins and of the DNA |
06/21/1989 | EP0321271A2 Method for producing the HgiAI restriction endonuclease and methylase |
06/21/1989 | EP0321270A2 Method for producing the HhaI restriction endonuclease and methylase |
06/21/1989 | EP0321269A2 Method for producing the HinPI restriction endonuclease and methylase |
06/21/1989 | EP0321267A2 Method for producing the AccI restriction endonuclease and methylase |
06/21/1989 | EP0321266A2 Method for producing the FokI restriction endonuclease and methylase |
06/21/1989 | EP0321249A2 Agent for and method of diagnosis of varicella zoster virus infection |
06/21/1989 | EP0321201A2 Ribozymes |
06/21/1989 | EP0321196A2 780 T-dna gene transcription activator |
06/21/1989 | EP0320994A1 Plasmid and a method for producing thereof |
06/21/1989 | EP0320807A2 Novel polynucleotide analogs, methods for inhibiting nucleic acid polymerases and methods for inducing synthesis of interferon |
06/21/1989 | EP0320806A2 T-cell activation related gene |
06/21/1989 | EP0293391A4 Cloned streptococcal genes encoding protein g and their use to construct recombinant microorganisms to produce protein g. |
06/21/1989 | EP0238631A4 Immunoassay method and kit. |
06/20/1989 | US4840896 Human fertility hormones rna encoding by vectors |
06/20/1989 | US4840895 Monoclonal antibodies reactive with immune complexes |
06/20/1989 | US4840894 Using protein antibody complex |
06/20/1989 | CA1256042A1 Process for the purification of hbsag |
06/15/1989 | WO1989005359A1 Detection of salmonella |
06/15/1989 | WO1989005358A1 Dna and rna molecules stabilized by modifications of the 3'-terminal phosphodiester linkage and their use as nucleic acid probes and as therapeutic agents to block the expression of specifically targeted genes |
06/15/1989 | WO1989005355A1 Retinoic acid receptor composition and method |
06/15/1989 | WO1989005353A1 Common acute lymphoblastic leukemia antigen |
06/15/1989 | WO1989005352A1 DNA ENCODING IgE RECEPTOR alpha-SUBUNIT OR FRAGMENT THEREOF |
06/15/1989 | WO1989005350A1 Dna encoding acv synthetase |
06/15/1989 | WO1989005349A1 Method of combating viral infections |